Page 258 - Remedial Andrology

1789. Vanegas, J.C., et al. Discrete survival model analysis of a couple’s smoking pattern and outcomes of
assisted reproduction. Fertil Res Pract, 2017. 3.
https://pubmed.ncbi.nlm.nih.gov/28480049
1790. Ricci, E., et al. Semen quality and alcohol intake: a systematic review and meta-analysis. Reprod
Biomed Online, 2017. 34: 38.
https://pubmed.ncbi.nlm.nih.gov/28029592
1791. NIAAA, The Physicians’ guide to helping patients with alcohol problems. 1995.
1792. Muthusami, K.R., et al. Effect of chronic alcoholism on male fertility hormones and semen quality.
Fertil Steril, 2005. 84: 919.
https://pubmed.ncbi.nlm.nih.gov/16213844
1793. Sidorkiewicz, I., et al. Endocrine-disrupting chemicals-Mechanisms of action on male reproductive
system. Toxicol Ind Health, 2017. 33: 601.
https://pubmed.ncbi.nlm.nih.gov/28464759
1794. Agarwal, A., et al. Correlation of reactive oxygen species levels with the fertilization rate after in vitro
fertilization: a qualified meta-analysis. Fertil Steril, 2005. 84: 228.
https://pubmed.ncbi.nlm.nih.gov/16009190
1795. Showell, M.G., et al. Antioxidants for male subfertility. Cochrane Database Syst Rev, 2014:
Cd007411.
https://pubmed.ncbi.nlm.nih.gov/25504418
1796. Smits, R.M., et al. Antioxidants for male subfertility. Cochrane Database Syst Rev, 2019. 3:
Cd007411.
https://pubmed.ncbi.nlm.nih.gov/30866036
1797. Steiner, A.Z., et al. The effect of antioxidants on male factor infertility: the Males, Antioxidants, and
Infertility (MOXI) randomized clinical trial. Fertil Steril, 2020. 113: 552.
https://pubmed.ncbi.nlm.nih.gov/32111479
1798. Cannarella, R., et al. Effects of the selective estrogen receptor modulators for the treatment of male
infertility: a systematic review and meta-analysis. Expert Opin Pharmacother, 2019. 20: 1517.
https://pubmed.ncbi.nlm.nih.gov/31120775
1799. Kamischke, A., et al. Analysis of medical treatment of male infertility. Hum Reprod, 1999. 14 Suppl 1: 1.
https://pubmed.ncbi.nlm.nih.gov/10573021
1800. Chua, M.E., et al. Revisiting oestrogen antagonists (clomiphene or tamoxifen) as medical empiric
therapy for idiopathic male infertility: a meta-analysis. Andrology, 2013. 1: 749.
https://pubmed.ncbi.nlm.nih.gov/23970453
1801. Cooke, P.S., et al. Estrogens in Male Physiology. Physiol Rev, 2017. 97: 995.
https://pubmed.ncbi.nlm.nih.gov/28539434
1802. Schulster, M., et al. The role of estradiol in male reproductive function. Asian J Androl, 2016. 18: 435.
https://pubmed.ncbi.nlm.nih.gov/26908066
1803. Ring, J.D., et al. Current medical management of endocrine-related male infertility. Asian J Androl,
2016. 18: 357.
https://pubmed.ncbi.nlm.nih.gov/27098657
1804. Xu, X., et al. The Effect of Aromatase on the Reproductive Function of Obese Males. Horm Metab
Res, 2017. 49: 572.
https://pubmed.ncbi.nlm.nih.gov/28679145
1805. Del Giudice, F., et al. A systematic review and meta-analysis of clinical trials implementing
aromatase inhibitors to treat male infertility. Asian J Androl, 2019.
https://pubmed.ncbi.nlm.nih.gov/31621654
1806. El Meliegy, A., et al. Systematic review of hormone replacement therapy in the infertile man. Arab
J Urol, 2018. 16: 140.
https://pubmed.ncbi.nlm.nih.gov/29713545
1807. Jones, T.H., et al. Diurnal rhythm of testosterone induced by human chorionic gonadotrophin (hCG)
therapy in isolated hypogonadotrophic hypogonadism: a comparison between subcutaneous and
intramuscular hCG administration. Eur J Endocrinol, 1994. 131: 173.
https://pubmed.ncbi.nlm.nih.gov/8075787
1808. Guo, C.Y., et al. Treatment of isolated hypogonadotropic hypogonadism effect on bone mineral
density and bone turnover. J Clin Endocrinol Metab, 1997. 82: 658.
https://pubmed.ncbi.nlm.nih.gov/9024272
1809. Efficacy and safety of highly purified urinary follicle-stimulating hormone with human chorionic
gonadotropin for treating men with isolated hypogonadotropic hypogonadism. European Metrodin
HP Study Group. Fertil Steril, 1998. 70: 256.
https://pubmed.ncbi.nlm.nih.gov/9696217

SEXUAL AND REPRODUCTIVE HEALTH - MARCH 2021 257